Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy offers hope for stroke Survivors' shoulder pain

NCT ID NCT02893267

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two treatments for shoulder pain in people who had a stroke: a nerve stimulation technique and physical therapy. About 96 adults with lasting shoulder pain after a stroke took part. The goal was to see if combining both treatments works better than either one alone for long-term pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

96 people

The number who actually took part.

Start date

Jan 2017

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * shoulder pain localized to the glenohumeral joint, subacromial area or deltoid insertion associated with: a) rest; b) passive abduction or external rotation range of motion (ROM); c) active abduction ROM; or, d) manual palpation; * shoulder pain onset or worsening after the most recent stroke; * weakness of shoulder abductors (≤4/5 on Medical Research Council (MRC) scale if isolated movement is present); * ≥ 21-yrs old; \< 90-yrs old; * time of stroke ≥ 3-mo; * duration of HSP ≥3-mo; * HSP with moderate to severe pain (BPI SF-3 ≥ 4); * cognitive and communication ability to fulfill study requirements (cognitive ability based upon a score of ≥24 on the Mini Mental Status Exam (MMSE)); * availability of reliable adult who can assist with study procedures if necessary; * willing and able to report shoulder pain and other conditions and complete study visits throughout the 4 month study period. Exclusion Criteria: * joint or overlying skin infection or history of recurrent skin infections; * insensate skin; * need to take \> 1 opioid and \> 1 nonopioid analgesic medication for HSP; * regular intake of pain medications for another chronic pain; * botox injection or subacromial steroid injections to the shoulder within the past 12 weeks; * receiving occupational therapy (OT) or PT for HSP; * bleeding disorder or international normalized ratio (INR) \> 3.0; * sensitivity to skin surface electrodes and/or medical-grade adhesives, gels, tapes; * medical instability; * pregnancy; * uncontrolled seizures (\>1/mo for 6-mo); * history of cardiac arrhythmia with hemodynamic instability; * history of lidocaine allergy; * history of Parkinson's disease, spinal cord injury (SCI), traumatic brain injury (TBI), multiple sclerosis (MS), or ipsilateral upper extremity (UE) lower motor neuron lesion; * history of complex regional pain syndrome, myofacial pain syndrome, other pain conditions (investigator discretion); * cardiac pacemaker or other implanted electronic device; * history of valvular heart disease (artificial valves, requiring antibiotics for procedures, etc.); * severely impaired communication.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Shoulder pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Shoulder Pain stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carolinas Rehabilitation

    Charlotte, North Carolina, 28203, United States

  • MetroHealth Medical Center

    Cleveland, Ohio, 44109, United States

  • Shirley Ryan Abilitylab

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.